Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Prediction of Risk for Adverse Pregnancy Outcomes in Women with Sickle Cell Disease

A. Kinga Malinowski, MD MSc, FRCSC, Kevin H. M. Kuo, MDMSc,FRCPC, George A. Tomlinson, PhD BSc, MSc, Richard Ward, MSc, MRCP, FRCPath, Nadine Shehata, MDFRCPC,MSc

Blood (2019) 134 (Supplement_1): 1009.

https://doi.org/10.1182/blood-2019-130087

Published: 2019

Journal Articles

The Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomized, Multicenter, Open-Label, Phase II Study (STEADFAST)

Kenneth I. Ataga, MD, Santosh L. Saraf, MD, Vimal K. Derebail, MD, Claire C. Sharpe, Adlette Inati, MD, Jeffrey D. Lebensburger, DO, MSPH, Laurie DeBonnett, MD, Shirong Zhang, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1018.

https://doi.org/10.1182/blood-2019-124823

Published: 2019

Journal Articles

Plasma Cell Proliferative Index Is an Independent Predictor of Progression in Smoldering Multiple Myeloma

Blood (2018) 132 (Supplement 1): 3160.

https://doi.org/10.1182/blood-2018-99-114882

Published: 2018

Journal Articles

Carfilzomib-Associated Renal Toxicity Is Common and Unpredictable: An Analysis of 114 Patients

Blood (2018) 132 (Supplement 1): 1966.

https://doi.org/10.1182/blood-2018-99-112851

Published: 2018

Journal Articles

Patient Treatment Preferences for Relapsed/Refractory Multiple Myeloma: Are Patients Willing to Trade Off Efficacy for Tolerability?

Daniel Auclair, PhD, Carol Mansfield, PhD, Ajai Chari, MD, Craig E. Cole, MD, Mark A. Fiala, BS, Jonathan L Kaufman, MD, Gregory Orloff, MD, David S Siegel, MD PhD, Jeffrey A Zonder, MD, Brennan Mange, Jennifer Yesil, MS, Mehul Dalal, PhD, Joseph Mikhael, MD FRCPC, MD

Blood (2018) 132 (Supplement 1): 614.

https://doi.org/10.1182/blood-2018-99-113087

Published: 2018

Journal Articles

Clinical and Laboratory Predictors of 30-Day Hospital Readmission Risk in Adult Patients with Sickle Cell Disease

Seyed Mehdi Nouraie, PhD MD, Melissa Saul, MS, Enrico M Novelli, MD MS, Gregory J. Kato, MD, Mark T Gladwin, MD

Blood (2018) 132 (Supplement 1): 2384.

https://doi.org/10.1182/blood-2018-99-115248

Published: 2018

Journal Articles

Hemolytic, Vaso-Occlusive and Renal Complications of SCD: Report from the Central Missouri Cohort

Lila Wahidi Nolan, MD, Yilin Yoshida, PhD, Emily Coberly, MD, Bindu Kanathezhath Sathi, MD

Blood (2018) 132 (Supplement 1): 1091.

https://doi.org/10.1182/blood-2018-99-113723

Published: 2018

Journal Articles

Using "Big-Data" to Evaluate in-Hospital Morbidity and Mortality in Systemic Light Chain (AL) Amyloidosis after High Dose Therapy and Autologous Stem Cell Transplant (HDT/ASCT)

Binod Dhakal, MBBS, Xinran Qi, Guru Subramanian Guru Murthy, MBBS, Ravi Narra, MD, Aniko Szabo, PhD, Saurabh Chhabra, MD, Anita D'Souza, MBBS, Parameswaran Hari, MD MRCP, MS

Blood (2017) 130 (Supplement 1): 2170.

https://doi.org/10.1182/blood.V130.Suppl_1.2170.2170

Published: 2017

Journal Articles

Increased Toxicity Among Adolescents and Young Adults Treated for Acute Lymphoblastic Leukemia at U.S. Children's Hospitals

Ajay Gupta, MD, Yousif Matloub, MD, Rahul Damania, MD, MaryAnn O'Riordan, Sanjay P Ahuja, MD

Blood (2017) 130 (Supplement 1): 222.

https://doi.org/10.1182/blood.V130.Suppl_1.222.222

Published: 2017

Journal Articles

Modeling and Understanding the Biology of Transplant-Mediated HIV Cure in a Non-Human Primate Model

Blood (2017) 130 (Supplement 1): 694.

https://doi.org/10.1182/blood.V130.Suppl_1.694.694

Published: 2017

Journal Articles

Mortality Trends and Causes of Death in Persons with Sickle Cell Disease in the United States, 1979-2014

Amanda B. Payne, MPH, Jason M. Mehal, MSPH, Christina Chapman, MSPH, Dana L. Haberling, MSPH, Lisa C. Richardson, MDMPH, Christopher J. Bean, PhD, William C. Hooper, PhD

Blood (2017) 130 (Supplement 1): 865.

https://doi.org/10.1182/blood.V130.Suppl_1.865.865

Published: 2017

Journal Articles

Early Renal Disease in Children with Sickle Cell Disease from Malawi

Jonathan Brett Heimlich, Godwin Chipoka, MBBS, Graham Ellis, Laila Elsherif, PhD, Emeraghi David, Portia Kamthunzi, MBBS, Robert Krysiak, Yacinta Majawa, Pilirani Mafunga, Qingning Zhou, PhD, Jianwen Cai, PhD, Nigel S. Key, MB, ChB, FRCP,, Satish Gopal, Kenneth I. Ataga, MD

Blood (2016) 128 (22): 1316.

https://doi.org/10.1182/blood.V128.22.1316.1316

Published: 2016

Journal Articles

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Meletios A. Dimopoulos, Maria Roussou, Maria Gavriatopoulou, Erasmia Psimenou, Dimitrios Ziogas, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Panagiotidis, Argyrios Ntalianis, Evangelos Repasos, Elektra Papadopoulou, Kimon Stamatelopoulos, Efstathios Manios, Constantinos Pamboukas, Sofoklis Kontogiannis, Evangelos Terpos, Efstathios Kastritis, MD

Blood (2016) 128 (22): 4491.

https://doi.org/10.1182/blood.V128.22.4491.4491

Published: 2016

Journal Articles

Sickle Cell Disease Measures in the Phenx Toolkit

Kathryn L. Hassell, MD, James R. Eckman, MD, Elizabeth S Klings, MD, Robert J. Adams, MD MS, Julie A. Panepinto, MD MSPH, Tracey Grant, MS, Wayne Huggins, PhD, Deborah R. Maiese, MPA, Ellen M. Werner, PhD, Erin M. Ramos, PhD MPH, Carol M. Hamilton, PhD

Blood (2015) 126 (23): 281.

https://doi.org/10.1182/blood.V126.23.281.281

Published: 2015

Journal Articles

Defining the Incidence, Pathology and Clinical Outcomes of Kidney Disease Related to Waldenstrom's Macroglobulinemia and IgM MGUS

Josephine M. Vos, MD, Robert R Manning, Kirsten Meid, MPH, Joshua Gustine, MPH, Christopher J Patterson, MFA, Philip Brodsky, Sandra Kanan, NP, RN, MSN, Marie José Kersten, MD PhD, Steven P Treon, MD PhD, Jorge J Castillo, MD

Blood (2015) 126 (23): 3926.

https://doi.org/10.1182/blood.V126.23.3926.3926

Published: 2015

Journal Articles

Relationship of Carfilzomib Dosing and Duration of Therapy (DOT) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM)

R. Donald Harvey, Yaozhu J. Chen, MPA, Jan Lethen, Maya Mahue

Blood (2015) 126 (23): 4235.

https://doi.org/10.1182/blood.V126.23.4235.4235

Published: 2015

Journal Articles

Analysis of VDT-PACE Utilization in Multiple Myeloma Patients Treated at MSKCC for Relapsed Disease or Cytoreduction and Stem Cell Mobilization after Initial Induction Therapy

Kristen Beyer, PharmD, BCOP, Samuel Rosner, Kaitlin M Woo, MA, Sean M. Devlin, PhD, Heather Landau, MD, Hani Hassoun, MD, Nikoletta Lendvai, MD PhD, David J Chung, MD PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Marcin Puto, PharmD, BCOP, Ola Landgren, MD, PhD, Sergio Giralt, MD, Alexander M. Lesokhin, MD

Blood (2014) 124 (21): 3459.

https://doi.org/10.1182/blood.V124.21.3459.3459

Published: 2014

Journal Articles

Mass Spectrometry of Urine Proteins for Early Detection of Renal Complications in Sickle Cell Disease

Elena A Adjei, BS, Namita Kumari, PhD

Blood (2014) 124 (21): 2714.

https://doi.org/10.1182/blood.V124.21.2714.2714

Published: 2014

Journal Articles

How I treat renal complications in sickle cell disease

Claire C. Sharpe, Swee Lay Thein

Blood (2014) 123 (24): 3720–3726.

https://doi.org/10.1182/blood-2014-02-557439

Published: 2014

Journal Articles

Young and Old Sickle Cell Disease Transgenic Mice Present Underactive Bladder

Mário Angelo Claudino, B.Sc., Ph.D, Luiz Osório Leiria, Ph.D., Carla Fernanda Franco-Penteado, PhD, Fabio Henrique Silva, M.Sc, Marcus Corat, PhD, Edson Antunes, BSc, MSc, Ph.D, Fernando Ferreira Costa, MD, PhD

Blood (2013) 122 (21): 2248.

https://doi.org/10.1182/blood.V122.21.2248.2248

Published: 2013

NARROW

Prediction of Risk for Adverse Pregnancy Outcomes in Women with Sickle Cell Disease

The Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomized, Multicenter, Open-Label, Phase II Study (STEADFAST)

Plasma Cell Proliferative Index Is an Independent Predictor of Progression in Smoldering Multiple Myeloma

Carfilzomib-Associated Renal Toxicity Is Common and Unpredictable: An Analysis of 114 Patients

Patient Treatment Preferences for Relapsed/Refractory Multiple Myeloma: Are Patients Willing to Trade Off Efficacy for Tolerability?

Clinical and Laboratory Predictors of 30-Day Hospital Readmission Risk in Adult Patients with Sickle Cell Disease

Hemolytic, Vaso-Occlusive and Renal Complications of SCD: Report from the Central Missouri Cohort

Using "Big-Data" to Evaluate in-Hospital Morbidity and Mortality in Systemic Light Chain (AL) Amyloidosis after High Dose Therapy and Autologous Stem Cell Transplant (HDT/ASCT)

Increased Toxicity Among Adolescents and Young Adults Treated for Acute Lymphoblastic Leukemia at U.S. Children's Hospitals

Modeling and Understanding the Biology of Transplant-Mediated HIV Cure in a Non-Human Primate Model

Mortality Trends and Causes of Death in Persons with Sickle Cell Disease in the United States, 1979-2014

Early Renal Disease in Children with Sickle Cell Disease from Malawi

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Sickle Cell Disease Measures in the Phenx Toolkit

Defining the Incidence, Pathology and Clinical Outcomes of Kidney Disease Related to Waldenstrom's Macroglobulinemia and IgM MGUS

Relationship of Carfilzomib Dosing and Duration of Therapy (DOT) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM)

Analysis of VDT-PACE Utilization in Multiple Myeloma Patients Treated at MSKCC for Relapsed Disease or Cytoreduction and Stem Cell Mobilization after Initial Induction Therapy

Mass Spectrometry of Urine Proteins for Early Detection of Renal Complications in Sickle Cell Disease

How I treat renal complications in sickle cell disease

Young and Old Sickle Cell Disease Transgenic Mice Present Underactive Bladder

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only